Mdxhealth SA revenue

Mdxhealth SA's revenue was $108m in fiscal 2025, up 19.8% on the year before. Since fiscal 2019 ($11.8m) it has grown at a compound 44.6% a year.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Mdxhealth SA: revenue history, annual
Fiscal year	2019Dec 2019	2020Dec 2020	2021Dec 2021	2022Dec 2022	2023Dec 2023	2024Dec 2024	2025Dec 2025
Revenue	12	18	22	37	70	90	108
Growth on the year before	—	+56.6%	+20.5%	+66.6%	+89.4%	+28.3%	+19.8%
Gross profit	0	8	11	19	44	55	70
Gross margin	0.3%	43.6%	47.5%	51.9%	62.6%	61.2%	64.5%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Life Sciences Tools & Services: the closest covered companies by revenue. Last twelve months.

Company	Revenue	Growth	3-year growth a year
Mdxhealth SA	$108m	19.8%	—
Biodesix Inc	$103m	34.5%	35.2%
Harvard Bioscience Inc	$87.8m	-1.1%	-8.4%
Codexis, Inc.	$77.7m	35.9%	-7.8%
Quanterix Corp	$153m	22.0%	11.1%
Burning Rock Biotech Ltd	$75.1m	4.7%	—

Compare with peers

Head to head: BDSX vs MDXH HBIO vs MDXH CDXS vs MDXH

More: Life Sciences Tools & Services stocks compared, Health Care sector, rankings of US companies

Figures from Mdxhealth SA's SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Mdxhealth SA.